Hinge Health, a leader in digital health solutions, has officially priced its initial public offering (IPO) at $32 per share. This decision was announced on May 21, 2025, and includes a total of 13,666,000 shares of Class A common stock available to investors. Among these, Hinge Health will sell 8,522,528 shares, while the remaining 5,143,472 shares will be sold by certain existing stockholders.
"We are excited to take this significant step towards becoming a publicly traded company," said Hinge Health CEO, Daniel Perez. The anticipated trading of Hinge Health’s shares on the New York Stock Exchange is set to commence on May 22, 2025, under the ticker symbol "HNGE." The official close of the offering is expected to occur the following day, May 23, 2025, contingent upon customary closing conditions.
In addition to the direct share sales, selling stockholders have provided underwriters with a 30-day option to purchase an additional 2,049,900 shares at the initial offering price. This flexibility aims to enhance market interest and ensure a robust trading environment post-IPO.
Hinge Health’s strategy for the net proceeds from the offering is focused on addressing tax withholding obligations associated with the stock units. "Most of our proceeds will be directed towards fulfilling tax obligations linked to the vesting and settlement of restricted stock units," Perez added. It is important to note that Hinge Health will not benefit from any financial proceeds generated from the sales by the selling stockholders.
The underwriting team for this IPO is led by prominent financial institutions, including Morgan Stanley, Barclays, and BofA Securities, which will serve as the lead book-running managers. In total, the book-running manager lineup consists of several other respected firms such as Evercore ISI and RBC Capital Markets.
As stated in the company's prospectus, the registration statement for this IPO has been filed with the Securities and Exchange Commission and has received the necessary approvals. Investors interested in obtaining copies of the prospectus can do so through the respective managers’ contact details provided in the announcement.
Hinge Health is at the forefront of healthcare technology, harnessing AI and advanced software to automate care for musculoskeletal (MSK) health. "Our platform is designed to improve member outcomes while driving costs down for our clients," explained Perez, emphasizing the company's commitment to delivering a superior experience for users. Hinge Health addresses a comprehensive range of MSK issues, including acute injuries and chronic pain, facilitating rehabilitation without the need for surgical interventions.
The company’s unique approach not only enhances user engagement but also promotes health equity by enabling members to participate in their care from virtually anywhere. With its headquarters in San Francisco, Hinge Health is poised to capitalize on the growing demand for digital health solutions.
With the IPO just around the corner and significant interest brewing among investors, Hinge Health is ready to make its mark on the public market, paving the way for further innovations in joint and muscle care services.